A drug‐repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6‐thioguanine as an effective therapeutic agent for TPMT‐low cancer cells
Inki Kim(Asan Medical Center), Suhwan Chang(Ulsan College), Eun Ji Lee(Ulsan College), Sojung Park(Asan Medical Center), Eun A Choi(Ulsan College), Yeon‐Sook Choi(Ulsan College), Je‐Keun Rhee(Soongsil University), Jae Hwi Song(Ulsan College), Song Cheol Kim(Ulsan College)
Cited by 35
Related Papers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
|Journal of Controlled Release|2016|260